1. Written signed and dated informed consent (patient or LAR). <br/ >2. Either gender, in the age group between 18 to 75 years <br/ >3. Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or <br/ >oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of <br/ >COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4. A score of between 3 to 4 on the Modified WHO Ordinal Scale for Clinical <br/ >Improvement (refer protocol appendix 23.1) <br/ >5. SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6. Patients who provide a agree to abide by the study requirements

1. Written signed and dated informed consent (patient or LAR). <br/ >2. Either gender, in the age group between 18 to 75 years <br/ >3. Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or <br/ >oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of <br/ >COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4. A score of between 3 to 4 on the Modified WHO Ordinal Scale for Clinical <br/ >Improvement (refer protocol appendix 23.1) <br/ >5. SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6. Patients who provide a agree to abide by the study requirements

1. Written signed and dated informed consent (patient or LAR). <br/ >2. Either gender, in the age group between 18 to 75 years <br/ >3. Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4. A score of between 3 to 5 on the Modified WHO Ordinal Scale for Clinical Improvement (refer protocol appendix 23.1) <br/ >5. SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6. Patients who provide a agree to abide by the study requirements <br/ >

1. Written signed and dated informed consent (patient or LAR). <br/ >2. Either gender, in the age group between 18 to 75 years <br/ >3. Patients of laboratory confirmed COVID-19 [nasopharyngeal (preferred) or oropharyngeal swab RT-PCR positive] presenting with WHO listed symptoms of COVID-19 c/o fever, headache, myalgia, cough, throat pain or shortness of breath <br/ >4. A score of between 3 to 5 on the Modified WHO Ordinal Scale for Clinical Improvement (refer protocol appendix 23.1) <br/ >5. SpO2 â?¥90% for adults and respiratory rate â?¤ 30/minute <br/ >6. Patients who provide a agree to abide by the study requirements <br/ >